Reasons for Ineligibility in phase 1 and 2A HIV Vaccine Initiative (KAVI), Kenya
View/ Open
Date
2011Author
Omosa-Manyonyi, Gloria S.
Omu Anzala, Walter Jaoko
Ogutu, Hilda
Wakasiaka, Sabina
Malogo, Roselyn
Nyange, Jacqueline
Njuguna, Pamela
Ndinya-Achola, JO
Bhatt, Kirana
Bashir, Farah
Oyaro, Micah
Schmidt, Claudia
Priddy, Frances
Fast, Patricia
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
With the persistent challenges towards controlling the HIV epidemic, there is an ongoing need for research
into HIV vaccines and drugs. Sub-Saharan African countries - worst affected by the HIV pandemic - have participated in the
conduct of clinical trials for HIV vaccines. In Kenya, the Kenya AIDS Vaccine Initiative (KAVI) at the University of Nairobi has
conducted HIV vaccine clinical trials since 2001
Citation
PLoS ONEPublisher
School of nursing science, University of Nairobi
Subject
Aids Vaccine InitiativeCollections
- Faculty of Health Sciences (FHS) [10378]